1 / 7

Heart Protection Study Collaborative Group Lancet 2005;365:1779

Estimated 5-year rate of a first major vascular event (MVE), major coronary event (MCE),or vascular death in univariate and multivariate risk subgroups. Heart Protection Study Collaborative Group Lancet 2005;365:1779.

teva
Download Presentation

Heart Protection Study Collaborative Group Lancet 2005;365:1779

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Estimated 5-year rate of a first major vascular event (MVE), major coronary event (MCE),or vascular death in univariate and multivariate risk subgroups Heart Protection Study Collaborative Group Lancet 2005;365:1779

  2. Total (first and subsequent) vascular and non-vascular outcomes during 5-year mean follow-up Heart Protection Study Collaborative Group Lancet 2005;365:1779

  3. Mean days in hospital and costs of hospitalisation per person during 5-year mean follow-up Heart Protection Study Collaborative Group Lancet 2005;365:1779

  4. Proportional reductions in vascular event costs with simvastatin allocation by prior disease,sex, age,LDL cholesterol,and multivariate risk subgroups Heart Protection Study Collaborative Group Lancet 2005;365:1779

  5. Days on statin and costs of statin per person during 5-year mean follow-up Heart Protection Study Collaborative Group Lancet 2005;365:1779

  6. Statin cost (￡) per person by baseline characteristics during 5-year mean follow-up Heart Protection Study Collaborative Group Lancet 2005;365:1779

  7. Reductions in 5-year vascular event costs (and 95%CI) with simvastatin allocation by baseline risk subgroups Heart Protection Study Collaborative Group Lancet 2005;365:1779

More Related